• CITALOPRAM CHEMBL549 FDA Approved

    Alternate Names:

    Citalopram
    Celexa
    TALOHEXAL
    LS-84327
    CITALEC
    NITALAPRAM
    CIPRAM
    WSEQXVZVJXJVFP-UHFFFAOYSA-
    CPD000465669
    [3H]CITALOPRAM
    LU-10-171
    AC1L1EFH
    HMS2090O09
    CILIFT
    CITALOPRAMUM
    CITALOPRAMUM [INN-LATIN]
    CHEBI:3723
    183529
    CITALOPRAM [CELEXA]
    D07704
    SEROPRAM
    5-ISOBENZOFURANCARBONITRILE, 1-(3-(DIMETHYLAMINO)PROPYL)-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-
    CYTALOPRAM
    AE-641/00603021
    C20H21FN2O
    TALAM
    C07572
    VODELAX
    AKARIN
    2771
    CITOPAM
    LOPAC0_000258
    1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-2-BENZOFURAN-5-CARBONITRILE
    CITALOPRAM [INN:BAN]
    L001223
    1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-3H-2-BENZOFURAN-5-CARBONITRILE
    CIPRAPINE
    SAM002589960
    CITALOPRAM (USP/INN)
    1-(3-(DIMETHYLAMINO)PROPYL)-1-(P-FLUOROPHENYL)-5-PHTHALANCARBONITRILE
    STL058639
    DB00215
    LU 10-171
    AC-12214
    OROPRAM
    TEMPERAX
    ZENTIUS
    CITADUR
    INCHI=1/C20H21FN2O/C1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/H4-9,12H,3,10-11,14H2,1-2H3
    NCGC00025160-02
    BPBIO1_000929
    CITABAX
    BSPBIO_000843
    HUMORUP
    CITADUR (TN)
    ZETALO
    1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-
    I01-0382
    BRD-A47598013-004-02-0
    ST069372
    PRESTWICK3_000692
    MOLPORT-003-666-794
    DAP000118
    DALSAN
    1,3-DIHYDRO-1-(3-(DIMETHYLAMINO)PROPYL)-1-(4-FLUOROPHENYL)-5-ISOBENZOFURANCARBONITRILE
    UNII-0DHU5B8D6V
    RECITAL
    EINECS 261-891-1
    CID2771
    5-ISOBENZOFURANCARBONITRILE, 1,3-DIHYDRO-1-(3-(DIMETHYLAMINO)PROPYL)-1-(4-FLUOROPHENYL)-
    CELAPRAM
    CIAZIL
    HMS2093A14
    CELIUS
    AB00513896
    59729-33-8
    NCGC00015267-07
    PRAMCIT
    1,3-DIHYDRO[3,4]BENZOFURAN-5-CARBONITRILE
    CHEBI:77397
    ELOPRAM
    BONITRILE
    1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-5-ISOBENZO[B]FURANCARBONITRILE
    1-[3-(DIMETHYLAMINO) PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-5-ISOBENZOFURAN CARBONITRILE
    AB00513896-11
    AB00513896-09
    4793-EP2305648A1
    4793-EP2298765A1
    4793-EP2298764A1
    4793-EP2284166A1
    4793-EP2275420A1
    FT-0657967
    KB-217184
    HE358063
    HE175796
    HE062045
    BC204213
    NCGC00015267-09
    NCGC00015267-05
    NCGC00015267-04
    VA10838
    NC00711
    MCULE-5882770916
    CCG-204353
    AN-5829
    AKOS005711003
    BBL029066
    ACT02666
    HMS3259B10
    HMDB05038
    BDBM25870
    GTPL7547
    GTPL4621
    5-ISOBENZOFURANCARBONITRILE,1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-
    5-CYANO-1-(4-FLUOROPHENYL)-1-(3-DIMETHYLAMINOPROPYL)-1,3-DIHYDRO-ISOBENZOFURAN
    5-CYANO-1-(4-FLUOROPHENYL)-1-(3 -DIMETHYLAMINOPROPYL)-1,3-DIHYDRO-ISOBENZOFURAN
    1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO[3,4]BENZOFURAN-5-CARBONITRILE
    CIPRAMILREG
    SMR000465669
    1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-3H-ISOBENZOFURAN-5-CARBONITRILE
    [3H]-CITALOPRAM
    WSEQXVZVJXJVFP-UHFFFAOYSA-N
    MLS006011858
    MLS000028578
    CITALOPRAM [USP:INN:BAN]
    SCHEMBL946
    [3H]LEXAPRO
    [3H]ESCITALOPRAM
    5-ISOBENZOFURANCARBONITRILE, 1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-
    [3H]CYTALOPRAM
    PERRIGO CITALOPRAM
    1-[3-(DIMETHYLAMINO)PROPYL]-1-(P-FLUOROPHENYL)-5-PHTHALANCARBONITRILE
    NITALAPRAM HBR
    CELEXAREG
    223365883
    7547

    Drug Info:

    FDA Approval 1998
    Drug Class small molecule
    Drug Indications Antidepressive Agents, Second-Generation
    Drug Class antidepressive agents, second-generation
    Year of Approval 1998
    (2 More Sources)

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Inhibition of [<sup>3</sup>H]dopamine uptake at human NET expressed in COS7 cells.
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Displacement of [<sup>3</sup>H]citalopram from human SERT expressed in HEK293 cells.
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    CITALOPRAM Primary Drug Name

    Drug Info:
    Year of Approval 1998
    Drug Class antidepressive agents, second-generation

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Antidepressive Agents, Second-Generation
    Drug Class small molecule
    FDA Approval 1998

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    1,3-DIHYDRO[3,4]BENZOFURAN-5-CARBONITRILE Drug Synonym
    PRAMCIT Drug Synonym
    59729-33-8 Drug Synonym

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    CELEXAREG Drug Synonym
    CITADUR Drug Synonym
    NITALAPRAM HBR Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    CITALOPRAM GuideToPharmacology Ligand Name
    223365883 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 15-September-2017

    Alternate Names:

    Drug Info:

    Publications: